In early-phase clinical research, chemical challenge agents offer a fast, reliable way to demonstrate proof of mechanism - showing whether a drug works as intended.
This webinar will explain how SGS applies these models to accelerate development by safely generating early efficacy data that support stronger funding and go/no-go decisions.
Learn how chemical challenge agents work, when to apply them and how SGS’ proven approach helps pharma and biotech teams gain meaningful early efficacy insights safely and efficiently.
The webinar is designed for small to mid-sized biotech companies in early clinical development, including CSOs, CMOs, clinical program leads, scientific directors and decision-makers seeking faster, data-driven proof of mechanism to guide development strategy.
This event takes place on December 4, 2025, at 03:00 PM CET.
